Halfdan Sorbye (H Sorbye)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Transcranial Magnetic Stimulation

Ejection Fraction

Top Venues

Journal of neuroendocrinology

Health and quality of life outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Halfdan Sorbye, G O Hjortland, L W Vestermark, A Sundlov, J Assmus, A Couvelard, A Perren, S W Langer
NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasms. Journal of neuroendocrinology (2024)
Halfdan Sorbye, Grace Kong, Simona Grozinsky-Glasberg, Jonathan R Strosberg
PRRT in high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). Journal of neuroendocrinology (2024)
Halfdan Sorbye, Enrique Grande, Marianne Pavel, Margot Tesselaar, Nicola Fazio, Nicholas Simon Reed, Ulrich Knigge, Emanuel Christ, Valentina Ambrosini, Anne Couvelard, Eva Tiensuu Janson
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma. Journal of neuroendocrinology (2023)
Hege Elvebakken, Geir Olav Hjortland, Herish Garresori, Per Arne Andresen, Emiel A M Janssen, Olav Karsten Vintermyr, Inger M B Lothe, Halfdan Sorbye
Impact of KRAS and BRAF mutations on treatment efficacy and survival in high-grade gastroenteropancreatic neuroendocrine neoplasms. Journal of neuroendocrinology (2023)
Rodney John Hicks, Clarisse Dromain, Wouter W de Herder, Frederico P Costa, Christophe M Deroose, Andrea Frilling, Anna Koumarianou, Eric P Krenning, Eric Raymond, Lisa Bodei, Halfdan Sorbye, Staffan Welin, Bertram Wiedenmann, Damian Wild, James R Howe, James C Yao, Dermot O'Toole, Anders Sundin, Vikas Prasad
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. Journal of neuroendocrinology (2021)
Halfdan Sorbye, Liv Sylvi Meyer, Kjersti Elisabeth Mordal, Simen Myhre, Espen Thiis-Evensen
Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours. Health and quality of life outcomes 18 (1) (2020)